Literature DB >> 25186228

The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology.

Jochen Schmitt1, Christian Apfelbacher2, Phyllis I Spuls3, Kim S Thomas4, Eric L Simpson5, Masutaka Furue6, Joanne Chalmers4, Hywel C Williams4.   

Abstract

Core outcome sets (COSs) are consensus-derived minimum sets of outcomes to be assessed in a specific situation. COSs are being increasingly developed to limit outcome-reporting bias, allow comparisons across trials, and strengthen clinical decision making. Despite the increasing interest in outcomes research, methods to develop COSs have not yet been standardized. The aim of this paper is to present the Harmonizing Outcomes Measures for Eczema (HOME) roadmap for the development and implementation of COSs, which was developed on the basis of our experience in the standardization of outcome measurements for atopic eczema. Following the establishment of a panel representing all relevant stakeholders and a research team experienced in outcomes research, the scope and setting of the core set should be defined. The next steps are the definition of a core set of outcome domains such as symptoms or quality of life, followed by the identification or development and validation of appropriate outcome measurement instruments to measure these core domains. Finally, the consented COS needs to be disseminated, implemented, and reviewed. We believe that the HOME roadmap is a useful methodological framework to develop COSs in dermatology, with the ultimate goal of better decision making and promoting patient-centered health care.

Entities:  

Mesh:

Year:  2014        PMID: 25186228     DOI: 10.1038/jid.2014.320

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  50 in total

1.  Coloring by Number? Core Outcome Measures and the Canvas of Intensive Care Unit Survivorship.

Authors:  Bronwen Connolly; Catherine L Hough
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

Review 2.  The COMET Handbook: version 1.0.

Authors:  Paula R Williamson; Douglas G Altman; Heather Bagley; Karen L Barnes; Jane M Blazeby; Sara T Brookes; Mike Clarke; Elizabeth Gargon; Sarah Gorst; Nicola Harman; Jamie J Kirkham; Angus McNair; Cecilia A C Prinsen; Jochen Schmitt; Caroline B Terwee; Bridget Young
Journal:  Trials       Date:  2017-06-20       Impact factor: 2.279

3.  [What does pain intensity mean from the patient perspective? : A qualitative study on the patient perspective of pain intensity as an outcome parameter in treatment evaluation and on the interpretability of pain intensity measurements].

Authors:  K Neustadt; S Deckert; C Kopkow; A Preißler; B Bosse; C Funke; L Jacobi; P Mattenklodt; B Nagel; P Seidel; R Sittl; E Steffen; R Sabatowski; J Schmitt; U Kaiser
Journal:  Schmerz       Date:  2017-12       Impact factor: 1.107

4.  [Quality of life in dermatology. From measurement to practical implementation].

Authors:  K Müller; S Karrer; C Apfelbacher; C Blome; M Berneburg; M Koller
Journal:  Hautarzt       Date:  2015-04       Impact factor: 0.751

5.  [Clinical studies on multimodal pain therapy : Standardized measurement of therapy outcomes with a core outcome set].

Authors:  S Deckert; R Sabatowski; J Schmitt; U Kaiser
Journal:  Schmerz       Date:  2016-12       Impact factor: 1.107

Review 6.  [Objectifying results in total knee arthroplasty: Is "patient satisfaction" adequate].

Authors:  C Kopkow; J Schmitt; E Haase; T Lange; K-P Günther; J Lützner
Journal:  Orthopade       Date:  2015-04       Impact factor: 1.087

7.  [Patient perspectives in outcome research : Development of a focus group concept for collating patient perspectives on determination of effectiveness of multimodal pain therapy - A pilot study].

Authors:  K Neustadt; S Deckert; R Heineck; C Kopkow; A Preißler; R Sabatowski; J Schmitt; U Kaiser
Journal:  Schmerz       Date:  2017-04       Impact factor: 1.107

8.  Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.

Authors:  Kristina Callis Duffin; Joseph F Merola; Robin Christensen; John Latella; Amit Garg; Alice B Gottlieb; April W Armstrong
Journal:  JAMA Dermatol       Date:  2018-10-01       Impact factor: 10.282

9.  Identifying What to Measure in Acne Clinical Trials: First Steps towards Development of a Core Outcome Set.

Authors:  Alison M Layton; E Anne Eady; Diane M Thiboutot; Jerry Tan
Journal:  J Invest Dermatol       Date:  2017-04-27       Impact factor: 8.551

10.  Identifying the Impacts of Acne and the Use of Questionnaires to Detect These Impacts: A Systematic Literature Review.

Authors:  Hayley Smith; Alison M Layton; Diane Thiboutot; Abbey Smith; Heather Whitehouse; Waseem Ghumra; Meenakshi Verma; Jerry Tan; Georgina Jones; Kathryn Gilliland; Megha Patel; Elaine Otchere; Anne Eady
Journal:  Am J Clin Dermatol       Date:  2021-03       Impact factor: 7.403

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.